Hsa_circ_0102899 promotes epithelial-mesenchymal transition in non-small cell lung cancer

被引:0
|
作者
Wang, YanFei [1 ]
He, JieMing [2 ]
Liang, YongXue [2 ]
Xiong, DaLin [1 ]
机构
[1] Kunming Med Univ, Yanan Affiliated Hosp, Dept Thorac Surg, 245 East Renmin Rd, Kunming 650051, Yunnan, Peoples R China
[2] Kunming Med Univ, Yanan Affiliated Hosp, Dept Resp & Crit Care Med, 245 East Renmin Rd, Kunming 650051, Yunnan, Peoples R China
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2023年 / 25卷 / 11期
关键词
circ_0102899; microRNA-885-5p; Eukaryotic translation initiation factor 4 & gamma; 2; Non-small cell lung cancer; Epithelial-mesenchymal transition; HEPATOCELLULAR-CARCINOMA; MALIGNANT PROGRESSION; METASTASIS; PROLIFERATION; SUPPRESSION; PROGNOSIS;
D O I
10.1007/s12094-023-03220-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective The significance of circular RNAs (circRNAs) has been identified in the progression of non-small cell lung cancer (NSCLC). Consistently, our study probed the functional actions of hsa_circ_0102899 (circ_0102899) in NSCLC cells.Methods circ_0102899 expression was checked in NSCLC tissues, as well as its correlation with clinical characteristics of patients, Using A459 cells, transfection to alter gene expression was performed, thus measuring the changes of proliferation, apoptosis, migration, and apoptosis, as well as epithelial-mesenchymal transition (EMT)-related proteins. circ_0102899's effects in vivo were validated by tumor xenograft assay. Finally, the regulatory mechanism of circ_0102899 was investigated.Results circ_0102899 indicated a high-expression level in NSCLC tissues which was associated with NSCLC tumor characteristics. Functionally, circ_0102899 knockdown not only inhibited the growth and EMT process of NSCLC cells, but also inhibited tumor formation in vivo. In terms of the regulatory mechanism, circ_0102899 had a binding to miR-885-5p to target eukaryotic translation initiation factor 4?2 (EIF4G2). circ_0102899 mediated miR-885-5/EIF4G2 axis to accelerate the process of cell malignant behavior in NSCLC.Conclusion circ_0102899 promotes EMT and metastasis in NSCLC by regulating the miR-885-5p/EIF4G2 axis.
引用
收藏
页码:3252 / 3262
页数:11
相关论文
共 50 条
  • [21] Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer
    Fujiwara, Ayako
    Shintani, Yasushi
    Funaki, Soichiro
    Kawamura, Tomohiro
    Kimura, Toru
    Minami, Masato
    Okumura, Meinoshin
    [J]. LUNG CANCER, 2017, 106 : 8 - 16
  • [22] Thrombomodulin regulates doxorubicin sensitivity through epithelial-mesenchymal transition in non-small cell lung cancer
    Yang, Y.
    Cheng, B. -J.
    Lu, S.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (01) : 95 - 101
  • [23] Effects Of Hmgb1 On Epithelial-Mesenchymal Transition And Chemoresistance In Non-Small Cell Lung Cancer
    Chong, I. -W.
    Tsai, J. R.
    Liu, P. L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [24] Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition
    Kapeleris, Joanna
    Bark, Juliana Muller
    Ranjit, Shanon
    Richard, Derek
    Vela, Ian
    O'Byrne, Kenneth
    Punyadeera, Chamindie
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (12) : 3501 - 3510
  • [25] Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition
    Joanna Kapeleris
    Juliana Müller Bark
    Shanon Ranjit
    Derek Richard
    Ian Vela
    Kenneth O’Byrne
    Chamindie Punyadeera
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 3501 - 3510
  • [26] IL-6 promotes growth and epithelial-mesenchymal transition of CD133+cells of non-small cell lung cancer
    Lee, Soo Ok
    Yang, Xiaodong
    Duan, Shanzhou
    Tsai, Ying
    Strojny, Laura R.
    Keng, Peter
    Chen, Yuhchyau
    [J]. ONCOTARGET, 2016, 7 (06) : 6626 - 6638
  • [27] RETRACTION: Circ_0017247 accelerates epithelial-mesenchymal transition in non-small cell lung cancer (Retraction of Vol 23, Pg 256, 2019)
    Li, C. -H.
    Wang, Y. -B.
    Chen, K. -B.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7217 - 7217
  • [28] Salinomycin Overcomes Pemetrexed Resistance in Non-Small Cell Lung Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition
    Hwang, K.
    Oh, S.
    Kim, H.
    Jeong, E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [29] Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition
    Lin, Steven H.
    Wang, Jing
    Saintigny, Pierre
    Wu, Chia-Chin
    Giri, Uma
    Zhang, Jing
    Menju, Toshi
    Diao, Lixia
    Byers, Lauren
    Weinstein, John N.
    Coombes, Kevin R.
    Girard, Luc
    Komaki, Ritsuko
    Wistuba, Ignacio I.
    Date, Hiroshi
    Minna, John D.
    Heymach, John V.
    [J]. BMC GENOMICS, 2014, 15
  • [30] Kaempferol modulates the metastasis of human non-small cell lung cancer cells by inhibiting epithelial-mesenchymal transition
    Hang, Meng
    Zhao, Fan
    Chen, Shu-Bo
    Sun, Qing
    Zhang, Chun-Xiao
    [J]. BANGLADESH JOURNAL OF PHARMACOLOGY, 2015, 10 (02) : 267 - 270